Practice
IP agreements need to comply with local laws, cover potential risks, and provide solutions to issues that may arise during the term of the contract. We make sure to cover everything you care about, from structuring the deal, to negotiating and drafting.
The Hogan Lovells IP and technology transactions group understands the many ways IP can be commercialized for the benefit of your company.
With more than 400 IP professionals globally, we can help you determine the best approach to managing the identification, evaluation, and monetization of your IP rights. Many of our lawyers in our IP group have advanced degrees in scientific disciplines and are well-versed in the newest technological innovations. As a result, we’re able to anticipate our clients’ needs across every industry.
Our technology transactions lawyers regularly collaborate with other practice groups at the firm to prepare comprehensive solutions for issues that may arise during a transaction. We work closely with our M&A, tax, export, government contracts, finance, privacy, antitrust, and dispute resolution teams to help navigate all the nuances of technology transfer. Our ability to integrate our first-class regulatory, corporate, and commercial practices allows us to meet the unique demands of a wide range of clients, from small start-ups to the world’s largest companies.
Advising Novartis on the IP aspects of its landmark portfolio transformation transactions with GSK and Eli Lilly worth more than $23bn.
Advising Dell, Inc. on the US$3.055bn sale of its IT services division to NTT Data.
Advising IBM on the US$2.3bn sale of its x86 server business to Lenovo.
Advising Daimler AG and consortium partners Audi AG, BMW Group, in the acquisition of HERE, the digital mapping business held by Nokia.
Advising Ford Motor Company on its sale of Volvo Cars to Zhejiang Geely for US$1.8bn, including the negotiation of patent and software cross-licensing arrangements.
Representing the University of Wyoming in IP matters relating to a joint venture with General Electric (GE) for the development of a coal gasification research facility.
Advising Regal Entertainment Group on the development and licensing of software and related technology rights in connection with the IPO of a client affiliate.
Representation of Daiichi Sankyo in its co-commercialization agreement with AstraZeneca relating to MOVANTIK in the United States.
Representing a clean tech start-up on IP license and materials procurement agreements with European and South African vendors.
Assisting MoxieEnergy in connection with its agreement for the purchase of various power generation equipment and related services from Siemens, including the licensing of IP.
Band 1 for Commercial Contracts
Chambers Global
Tier 1 for Technology Transactions
The Legal 500 U.S.
Global IP Firm of the Year
Managing Intellectual Property Awards
